Literature DB >> 2200660

Overview of inhalation toxicology.

M A Dorato1.   

Abstract

The development of inhalation toxicology as a distinct discipline can be traced back well over one hundred years. The technology has advanced in terms of materials and designs used to construct inhalation chambers and the equipment used to generate controlled test atmospheres of a wide variety of gases, vapors, dusts, and droplets. Consideration of metered dose inhalers, a relatively recent concern, has led to the design of new equipment for administering this unique dosage form. The parameters used to evaluate inhalation toxicity are similar to those used for any other route of administration. In addition, there are some unique procedures for early screening of pulmonary toxicity, especially within a series of related chemicals.

Entities:  

Mesh:

Year:  1990        PMID: 2200660      PMCID: PMC1568347          DOI: 10.1289/ehp.85-1568347

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  16 in total

1.  Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation.

Authors:  J D Brain; D E Knudson; S P Sorokin; M A Davis
Journal:  Environ Res       Date:  1976-02       Impact factor: 6.498

2.  Animal inhalation exposure chambers.

Authors:  R G Hinners; J K Burkart; C L Punte
Journal:  Arch Environ Health       Date:  1968-02

3.  Sensory irritation of the upper airways by airborne chemicals.

Authors:  Y Alarie
Journal:  Toxicol Appl Pharmacol       Date:  1973-02       Impact factor: 4.219

4.  Bronchopulmonary lavage of small laboratory animals.

Authors:  J L Mauderly
Journal:  Lab Anim Sci       Date:  1977-04

5.  Nasal absorption of propranolol from different dosage forms by rats and dogs.

Authors:  A Hussain; S Hirai; R Bawarshi
Journal:  J Pharm Sci       Date:  1980-12       Impact factor: 3.534

6.  Pulmonary mechanics in conscious Fischer 344 rats: multiple evaluations using nonsurgical techniques.

Authors:  M A Dorato; K H Carlson; D L Copple
Journal:  Toxicol Appl Pharmacol       Date:  1983-05       Impact factor: 4.219

7.  Early damage indicators in the the lung I. Lactate dehydrogenase activity in the airways.

Authors:  R F Henderson; E G Damon; T R Henderson
Journal:  Toxicol Appl Pharmacol       Date:  1978-05       Impact factor: 4.219

8.  The major parameters affecting temperature inside inhalation chambers.

Authors:  D M Bernstein; R T Drew
Journal:  Am Ind Hyg Assoc J       Date:  1980-06

9.  Nasal drug delivery system of a quaternary ammonium compound: clofilium tosylate.

Authors:  K S Su; K M Campanale; C L Gries
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

10.  Inhalation exposure of animals.

Authors:  R F Phalen
Journal:  Environ Health Perspect       Date:  1976-08       Impact factor: 9.031

View more
  4 in total

1.  Development of a large-scale computer-controlled ozone inhalation exposure system for rodents.

Authors:  Gregory J Smith; Leon Walsh; Mark Higuchi; Samir N P Kelada
Journal:  Inhal Toxicol       Date:  2019-04-25       Impact factor: 2.724

2.  Pulmonary response after exposure to inhaled nickel hydroxide nanoparticles: short and long-term studies in mice.

Authors:  Patricia A Gillespie; Gi Soo Kang; Alison Elder; Robert Gelein; Lu Chen; Andre L Moreira; Jeffrey Koberstein; Kam-Meng Tchou-Wong; Terry Gordon; Lung Chi Chen
Journal:  Nanotoxicology       Date:  2010-03-01       Impact factor: 5.913

Review 3.  Pharmaceutical aerosols for the treatment and prevention of tuberculosis.

Authors:  Shumaila N M Hanif; Lucila Garcia-Contreras
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

Review 4.  New Approach Methods to Evaluate Health Risks of Air Pollutants: Critical Design Considerations for In Vitro Exposure Testing.

Authors:  Jose Zavala; Anastasia N Freedman; John T Szilagyi; Ilona Jaspers; John F Wambaugh; Mark Higuchi; Julia E Rager
Journal:  Int J Environ Res Public Health       Date:  2020-03-23       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.